Merrimack Pharmaceuticals In a research report sent to investors Wednesday, Cowen’s top analyst Eric Schmidt reiterated a Market Perform rating on shares of Merrimack …
Merrimack Pharmaceuticals Inc (NASDAQ:MACK) announced that it has commenced operating as a new, refocused research and clinical development company in connection with the …
Merrimack Pharmaceuticals, Inc. (NASDAQ:MACK) announced that, at its Special Meeting of Stockholders held today, its stockholders voted to approve the asset sale with …
Merrimack Pharmaceuticals, Inc (NASDAQ:MACK) announced its fourth quarter and full year 2016 financial results for the period ended December 31, 2016. Key Recent …
As earnings season rolls to the foreground and key biotech players like Gilead Sciences, Inc. (NASDAQ:GILD), Merrimack Pharmaceuticals Inc (NASDAQ:MACK), ACADIA Pharmaceuticals Inc.
Merrimack Pharmaceuticals Inc (NASDAQ:MACK) announced that Richard Peters, M.D.
In a research report released today, Cowen analyst Eric Schmidt reiterated a Market Perform rating on shares of Merrimack Pharmaceuticals Inc (NASDAQ:MACK), after …
Merrimack Pharmaceuticals Inc (NASDAQ:MACK) announced that it has entered into a definitive asset purchase and sale agreement with Ipsen (Euronext: IPN; ADR: IPSEY) …
Merrimack Pharmaceuticals Inc(NASDAQ: MACK) announced that, following a recent independent Data and Safety Monitoring Board (DSMB) recommendation and subsequent futility analysis, it has decided …
Merrimack Pharmaceuticals Inc (NASDAQ:MACK) announced its third quarter 2016 financial results. Merrimack will host a live conference call and webcast today, Wednesday, November …